For the Inventor, By the Inventor

Enter assignee name

Foster City, CA, United States of America

Terns Pharmaceuticals, Inc.

USPTO Granted Patents = 13

EPO Patents = 4

Forward Citations = 14

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

F Anthony Romero (11 out of 42 patents)

Christopher T Jones (9 out of 9 patents)

Corey Reeves (8 out of 8 patents)

4. Martijn Fenaux (7 out of 18 patents)

5. Randall Halcomb (4 out of 46 patents)

6. Yingzi Xu (4 out of 8 patents)

7. Thorsten A Kirschberg (4 out of 44 patents)

8. Gary W Luehr (3 out of 3 patents)

9. Kevin P Quinn (2 out of 2 patents)

10. Olivia D Teal (1 out of 1 patent)

11. Jeffrey R Jasper (1 out of 1 patent)

12. Shanghai Yu (0 patent)

13. Ben Li (0 patent)

14. Ben Li (0 patent)

15. Shanghai Yu (0 patent)

13 patents: Sort by Forward Citations

1. 12528791 - Thyroid hormone receptor beta agonist compounds (2026-01-20),

2. 12522596 - Compounds as GLP-1R agonists (2026-01-13),

3. 12486261 - Compounds as GLP-1R agonists (2025-12-02),

4. 12485118 - Combinations of GLP-1R and THRβ agonists and methods of use thereof (2025-12-02),

5. 12454524 - (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias (2025-10-28),

6. 12410163 - Compounds as GLP-IR agonists (2025-09-09),

7. 12398127 - Thyroid hormone receptor beta agonist compounds (2025-08-26),

8. 12378239 - Compounds as GLP-1R agonists (2025-08-05),

9. 12378238 - Compounds as GLP-1R agonists (2025-08-05),

10. 12378237 - Compounds as GLP-1R agonists (2025-08-05),

11. 12378236 - Compounds as GLP-1R agonists (2025-08-05),

12. 12240835 - Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity (2025-03-04),

13. 12024507 - Compounds as GLP-1R agonists (2024-07-02),

Terns Pharmaceuticals, Inc. is a biotechnology company based in Foster City, California, focused on developing innovative therapies for liver diseases. The company specializes in advancing novel drug candidates that target specific pathways involved in liver health and metabolic disorders. Terns leverages cutting-edge research and technology to address unmet medical needs, aiming to improve patient outcomes through its commitment to scientific excellence and rigorous clinical development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#36 in Foster City, CA

#5,650 in California

#23,815 in US

#44,988 in the World

Foster City, CA, United States of America

Terns Pharmaceuticals, Inc.

Forward Citations = 14

15 inventors:

F Anthony Romero (11 out of 42 patents)

Christopher T Jones (9 out of 9 patents)

Corey Reeves (8 out of 8 patents)

4. Martijn Fenaux (7 out of 18 patents)

5. Randall Halcomb (4 out of 46 patents)

Please report any incorrect information to [email protected]

Loading…